VCYT
Price:
$47.41
Market Cap:
$3.75B
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Genomic Sequencing Classifier and Percepta Nasal Swab Test for lung cancer diagnosis; Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis; and Immunoscore Colon Cancer test for colon cancer diagnosis. It is also developing Percepta Genomic Atlas to hel...[Read more]
Industry
Biotechnology
IPO Date
2013-10-30
Stock Exchange
NASDAQ
Ticker
VCYT
According to Veracyte, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 124.76. This represents a change of -283.71% compared to the average of -67.91 of the last 4 quarters.
The mean historical PE Ratio of Veracyte, Inc. over the last ten years is -17.57. The current 124.76 PE Ratio has changed -71092.39% with respect to the historical average. Over the past ten years (40 quarters), VCYT's PE Ratio was at its highest in in the December 2024 quarter at 150.27. The PE Ratio was at its lowest in in the June 2025 quarter at -539.30.
Average
-17.57
Median
-23.55
Minimum
-78.16
Maximum
125.48
Discovering the peaks and valleys of Veracyte, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 285.99%
Maximum Annual PE Ratio = 125.48
Minimum Annual Increase = -567.17%
Minimum Annual PE Ratio = -78.16
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 125.48 | -567.17% |
| 2023 | -26.86 | -42.16% |
| 2022 | -46.44 | 25.46% |
| 2021 | -37.02 | -49.07% |
| 2020 | -72.68 | -7.01% |
| 2019 | -78.16 | 285.99% |
| 2018 | -20.25 | 183.38% |
| 2017 | -7.15 | 0.41% |
| 2016 | -7.12 | 28.40% |
| 2015 | -5.54 | -22.12% |
The current PE Ratio of Veracyte, Inc. (VCYT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
17.39
5-year avg
-11.50
10-year avg
-17.57
Veracyte, Inc.’s PE Ratio is greater than Kiniksa Pharmaceuticals, Ltd. (84.00), greater than Zai Lab Limited (-10.30), greater than Legend Biotech Corporation (-7.86), greater than Scholar Rock Holding Corporation (-14.54), greater than Disc Medicine, Inc. (-18.22), greater than Tarsus Pharmaceuticals, Inc. (-42.96), greater than IDEAYA Biosciences, Inc. (-9.62), greater than Apellis Pharmaceuticals, Inc. (62.16), less than Amicus Therapeutics, Inc. (154.43), greater than Adaptive Biotechnologies Corporation (-21.90),
| Company | PE Ratio | Market cap |
|---|---|---|
| 84.00 | $3.00B | |
| -10.30 | $2.21B | |
| -7.86 | $2.56B | |
| -14.54 | $4.61B | |
| -18.22 | $3.54B | |
| -42.96 | $3.47B | |
| -9.62 | $3.16B | |
| 62.16 | $2.81B | |
| 154.43 | $3.07B | |
| -21.90 | $2.66B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Veracyte, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Veracyte, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Veracyte, Inc.'s PE Ratio?
How is the PE Ratio calculated for Veracyte, Inc. (VCYT)?
What is the highest PE Ratio for Veracyte, Inc. (VCYT)?
What is the 3-year average PE Ratio for Veracyte, Inc. (VCYT)?
What is the 5-year average PE Ratio for Veracyte, Inc. (VCYT)?
How does the current PE Ratio for Veracyte, Inc. (VCYT) compare to its historical average?